Featured Posts

Sunday, February 10, 2019

NW Bio Releases Voting Results From Annual Shareholders' Meeting

BETHESDA, Md., Feb. 8, 2019 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) — ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today released the final voting results from the Annual Shareholder Meeting held on February...



from PR Newswire: https://prn.to/2UPqe9m

No comments:

Post a Comment